GRTS - Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Gritstone bio Inc. (GRTS) | Benzinga
LOS ANGELES, June 21, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming August 6, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Gritstone bio, Inc. ("Gritstone" or the "Company") (NASDAQ:GRTS) securities between March 9, 2023 and February 29, 2024, inclusive (the "Class Period").
If you suffered a loss on your Gritstone investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at www.glancylaw.com/cases/Gritstone-bio-Inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.
On February 12, 2024, Gritstone disclosed that it would be delaying the launch of its COVID-19 vaccine study (the "Phase 2b CORAL Study") from the first quarter of 2024 to Fall 2024 to "allow use of fully GMP-grade raw materials in the vaccine, which is expected to increase the regulatory ...
GRTS)>Full story available on Benzinga.com